targetfish

Bionaturis takes part in the annual meeting of the European project Targetfish

PhD Ana de las Heras, the person in charge of the Targetfish project within Bionaturis Group, attended the annual meeting of this European consortium intended to develop new vaccines for aquaculture.

During the meeting, held in the Universidad Autonoma of Barcelona, the activities of each of the 30 partners from 13 different countries were reviewed. From Bionaturis Group, Ana de las Heras explained the advances in new vaccine formulations for trout and seabass, being developed along other partners in Targetfish.

Moreover, Targetfish is working on the research of preventive treatments for other species such as salmon, seabream and turbot. All of them the most relevant species in the aquaculture industry in Europe.

A project for excellence

Led by PhD Geert Wiegertjes (Department of Animal Sciences, Cell Biology & Immunology group from Wageningen UR), Targetfish brings together leading European research groups that are experts on the fish immune system and enterprises from the Biotech and Veterinary sectors. This project, to be concluded in the fall of 2017, is funded by the European Commission 7th Framework programme.

If you want to know more about Targetfish, please click here.

November 5th, 2014|Blog english, congress, Press english|Comments Off|

Ana de las Heras: “The first year of Targetfish has been very satisfying”

Ph.D. Ana de las Heras is coordinating the participation of Bionaturis in Targetfish, the European consortium that is seeking solutions to the most common diseases in aquaculture. The balance after this first year is very positive.

-The research on health for aquaculture is one of the business activities in Bionaturis, what are the main milestones and where does the research head for? What are the next challenges?

Our goal is to offer innovative solutions for the prevention and control of diseases in aquaculture. We are focused on working in different and very important diseases for aquaculture, which, besides, will be useful as model for other ones. We expect to obtain soon the first results of testing new orally formulations in target species.

-In this way, Bionaturis is taking part in the European project Targetfish, that has just turned a year. What´s been the balance so far?

The first year has been very satisfying. Targetfish is a large consortium where most of the main European research groups that are working in immunology, fish pathology and aquaculture are taking part. All our effort is driven to obtain tangible solutions to the main diseases that are affecting European aquaculture. The consortium is very well-headed and there is a great commitment to achieve the set outcomes.

-Why is the research of health in aquaculture so important?

The world population is increasing and needs a first-class protein source. Aquaculture is essential to imbalance and satisfy the growing demand of aquatic products. Nowadays, aquaculture contributes nearly 50% of fish supply for human intake, and it is expected that in 2015 aquaculture will overtake the commercial fishing as main sources of fish protein. The increasing global demand of fish and shellfish, along with the limited capacity of […]

March 10th, 2014|Press english|0 Comments|

Two out of every three fish dishes will come from aquaculture in 2030

Aquaculture production is currently growing and will continue to do so in the coming years due to a substantial increase in demand. “According to the report ‘ fishing up to 2030: prospects for fishing and aquaculture”, released by the World Bank, the United Nations Organization for food and Agriculture (FAO) and the International Research Institute on food policies (IFPRI), two out of every three fish dishes in 2030 will come from aquaculture. In that year, It´s expected Asia – including Southeast Asia, China and Japan – to represent 70% of the global consumption of fish.

According to the study, both fishing and aquaculture are two important sources of employment and resources for developing countries. However, the diseases affecting aquaculture crop species are one of the main challenges and threats of the sector. To overcome that, Bionaturis works in preventive solutions such as oral vaccines intended to fight the most devastating salmon diseases. The company is also integrated in the European Targetfish project, dedicated to the research and development of preventive solutions for aquaculture, involving 30 partners from 13 different countries.

For further information about the aquaculture report, click here

  • Permalink Gallery

    Entrevista a Ana de las Heras sobre el proyecto europeo "Targetfish"

Entrevista a Ana de las Heras sobre el proyecto europeo "Targetfish"

November 9th, 2012|Blog english, video|0 Comments|

Bionaturis joins the “Targetfish” project

Targetfish:  key European project underway to improve aquaculture vaccines

This project mainly seeks to develop new vaccines for aquaculture, with a focus on the species and fighting against the diseases with the greatest economic impact in the European Union.

Targetfish is a biotechnological project involving 30 world-class partners from 13 different countries and with €6 million in funding.

 Bionaturis is established as one of the leading European companies in this sector. Dr. Ana de Las Heras will head the research for the scientific project at Bionaturis.

 

Bionaturis, a biotechnological company quoted on MAB since January, has signed up to the Targetfish project: the only major European project underway to develop aquaculture vaccines. This project, coordinated by Wageningen Universiteit (Netherland) and involving 30 world-class partners from 13 different countries, has  €6 million in funding. It will run for 5 years starting in October 2012.

Targetfish will advance the development of existing and new vaccines in order to protect such economically important species as Atlantic salmon, rainbow trout, common carp, sea bass, sea bream and turbot. It will also establish a knowledge base for the rational development of next-generation fish vaccines.

Bionaturis’ researcher Ana de las Heras, who holds a PhD in Veterinary Science, will head the Targetfish project in Bionaturis. The Spanish company will use its exclusive FLYLIFE  technology to develop vaccines for the project, including its recently patented formulations for oral delivery of recombinant vaccines.

Ana de las Heras stressed the socio-economic importance of the project for the European Union: “The lack of effective preventive treatment leads to large losses in this sector. Our FLYLIFE system is perfectly in line with the technical and economic requirements currently sought by producers”.

Thanks to its participation in Targetfish, Bionaturis is positioned as one […]

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.

CERRAR